In Depth 20 Sep 2022
Looming challenges for Europe’s cell and gene therapy space
The double whammy of Brexit and the COVID-19 pandemic have posed major logistical challenges for the development of cell and gene therapies (CGTs) in the last two years. In spite of these obstacles, Europe’s CGT market is catching up to that of the U.S. The CGT space experienced a shot in the arm in the […]